Re-challenge [177Lu]Lu-PSMA-617 in patients with advanced prostate cancer: outcome and safety

被引：0
|
作者：
Yordanova, Anna [2 ]
Essler, Markus [2 ]
Hauser, Stefan [3 ]
Feldmann, Georg [1 ]
Ahmadzadehfar, Hojjat [2 ]
机构：
[1] MED3 Univ Hosp Bonn, Dept Internal Med 3, Bonn, Germany
[2] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany
[3] Univ Hosp Bonn, Dept Urol, Bonn, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
526
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Radiation Safety Considerations of Household Waste Disposal After Release of Patients Who Have Received [177Lu]Lu-PSMA-617
    Graves, Stephen A.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (10) : 1567 - 1569
  • [42] Safety and Efficacy of [177Lu]Lu-rhPSMA-10.1 Re-Challenge Therapy in Progressive mCRPC after [177Lu] Lu-PSMA I&T Therapy: Preliminary Results
    Gaeble, A.
    Enke, J.
    Amerein, A.
    Viering, O.
    Rinscheid, A.
    Kircher, M.
    Wienand, G.
    Pfob, C.
    Lapa, C.
    Dierks, A.
    Bundschuh, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S654 - S655
  • [43] The impact of repeated cycles of radioligand therapy using [177Lu] Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer
    Yordanova, Anna
    Becker, Anja
    Eppard, Elisabeth
    Kuerpig, Stefan
    Fisang, Christian
    Feldmann, Georg
    Essler, Markus
    Ahmadzadehfar, Hojjat
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1473 - 1479
  • [44] Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617
    Martin, Sebastian
    Tonnesmann, Roswitha
    Hierlmeier, Ina
    Maus, Stephan
    Rosar, Florian
    Ruf, Juri
    Holland, Jason P.
    Ezziddin, Samer
    Bartholoma, Mark D.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (08) : 4960 - 4971
  • [45] Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
    Sartor, O.
    Gauna, D. E. Castellano
    Herrmann, K.
    de Bono, J. S.
    Shore, N. D.
    Chi, K. N. N.
    Crosby, M.
    Rodriguez, J. M. Piulats
    Flechon, A.
    Wei, X. X.
    Mahammedi, H.
    Roubaud, G.
    Ova, H.
    Ghebremariam, S.
    Kpamegan, E.
    Kreisl, T. N.
    Delgoshaie, N.
    Lehnhoff, K.
    Morris, M. J.
    Fizazi, K.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1324 - S1325
  • [46] Safety Analyses of the Phase 3 VISION Trial of [ 177 Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
    Chi, Kim N.
    Armstrong, Andrew J.
    Krause, Bernd J.
    Herrmann, Ken
    Rahbar, Kambiz
    de Bono, Johann S.
    Adra, Nabil
    Garje, Rohan
    Michalski, Jeff M.
    Kempel, Mette M.
    Fizazi, Karim
    Morris, Michael J.
    Sartor, Oliver
    Brackman, Marcia
    Desilvio, Michelle
    Wilke, Celine
    Holder, Geoffrey
    Tagawa, Scott T.
    [J]. EUROPEAN UROLOGY, 2024, 85 (04) : 382 - 391
  • [47] Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome
    Peters, Steffie M. B.
    Prive, Bastiaan M.
    de Bakker, Maarten
    de Lange, Frank
    Jentzen, Walter
    Eek, Annemarie
    Muselaers, Constantijn H. J.
    Mehra, Niven
    Witjes, J. Alfred
    Gotthardt, Martin
    Nagarajah, James
    Konijnenberg, Mark W.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (02) : 460 - 469
  • [48] Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome
    Steffie M. B. Peters
    Bastiaan M. Privé
    Maarten de Bakker
    Frank de Lange
    Walter Jentzen
    Annemarie Eek
    Constantijn H. J. Muselaers
    Niven Mehra
    J. Alfred Witjes
    Martin Gotthardt
    James Nagarajah
    Mark W. Konijnenberg
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 460 - 469
  • [49] A Population Pharmacokinetic Model Using Imaging Data to Assess Variability in Pharmacokinetics of [177Lu] Lu-PSMA-617 in Low Volume Metastatic Prostate Cancer Patients
    Siebinga, H.
    Prive, B. M.
    Peters, S. M. B.
    Nagarajah, J.
    De Wit-Van der Veen, B. J.
    Huitema, A. D. R.
    Hendrikx, J. J. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S125 - S125
  • [50] Practical Guidance on [177Lu]Lu-PSMA-617 Treatment, Including Radiation Safety, Adverse Event Monitoring, and Patient Counseling
    Spitz, Avery
    Floyd, Rebecca
    Sutton, Jennifer
    Gardner, Linda
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (05) : 539 - 547
12345